Background
PHC (Primary Hepatic Carcinoma)is one of the most common malignancies in China,which is a great threat to human health. The mortality has been reported to be the second in China. Transcatheter arterial chemoembolization (TACE) is a relatively new non-surgical treatment from 1980s. TACE combined with 125I seed PI(permenant implantation, PI) is an effective therapy for PHC,which can be regarded as the ideal alternative therapies for patients who have failed to respond to TACE alone. It has been...
| 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
